Rowe T C, Shearman R P, Fraser I S
Obstet Gynecol. 1979 Nov;54(5):535-43.
One hundred seventeen patients with amenorrhea and galactorrhea or hyperprolactinemia were evaluated with regard to antecedent factors, results of investigations, and management. Full details of the outcome of prolonged follow-up were available for 104 patients. Patients who developed amenorrhea-galactorrhea after withdrawal of oral contraceptives or postpartum had a lower incidence of pituitary adenomas than did those who developed amenorrhea-galactorrhea spontaneously. Six of a total of 40 tumors were detected only during the follow-up period. This study suggests that patients with spontaneous amenorrhea-galactorrhea have a greater risk of developing a detectable pituitary adenoma than do those with postpill or postpartum symptoms. However, patients with a microadenoma are more likely to have had postpill onset of hyperprolactinemia. Plasma prolactin (PRL) in patients with postpill amenorrhea-galactorrhea increased in proportion to the duration of oral contraceptive use.
对117例闭经、溢乳或高催乳素血症患者的既往因素、检查结果及治疗情况进行了评估。104例患者有长期随访结果的详细信息。停用口服避孕药或产后出现闭经-溢乳的患者垂体腺瘤发生率低于自发出现闭经-溢乳的患者。40个肿瘤中共有6个仅在随访期间被发现。本研究表明,自发闭经-溢乳患者比有 pill 后或产后症状的患者发生可检测到的垂体腺瘤的风险更高。然而,微腺瘤患者更可能在 pill 后出现高催乳素血症。 pill 后闭经-溢乳患者的血浆催乳素(PRL)水平随口服避孕药使用时间的延长而升高。